In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?

Heart Failure: In the United States

5-Year Outcomes for Heart Failure

Heart Failure in Europe

What Are the Goals for Uptitration?

Use of Medications in Patients Hospitalized With HF

How Do You Know When the Patient Is Decongested and Ready for Discharge?

Predischarge BNP Assay for Identifying Patients at High Risk for Readmission After Decompensated Heart Failure

Beta Blockade Use in Acute HF

Beta Blockade Use in Acute HF (cont)

Starting Beta Blockade in a De Novo HF Patient

Use of MRAs in Heart Failure Management

Impact of Evidence-Based HF Therapy Use at Hospital Discharge on Treatment Rates During Follow-Up

Recent Trials With Sacubitril/Valsartan

PIONEER HF: NT-proBNP Changes at 7 Days With Sacubitril/Valsartan

Transitioning From ACE Inhibitor or ARB to ARNI or Starting ARNI in the ACE Inhibitor/ARB De Novo Patient: Key Points From PIONEER HF

PIONEER HF: Key Subgroup Analyses

Benefit of Adding Ivabradine to an Inotrope in Severe Systolic Dysfunction

Ivabradine for Heart Failure

Early Discharge Period: Goals for Care

Early Discharge Period: Goals for Care (cont)

Abbreviations